BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38214937)

  • 1. Immunophenotyping with high-dimensional flow cytometry identifies Treg cell subsets associated with recurrence in papillary thyroid carcinoma.
    Li S; Chen Z; Liu M; Li L; Cai W; Lian ZX; Guan H; Xu B
    Endocr Relat Cancer; 2024 Mar; 31(3):. PubMed ID: 38214937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune profiling identifies CD8
    Chen Z; Guo ML; Li YY; Yan K; Li L; Shen F; Guan H; Liu QZ; Xu B; Lian ZX
    Front Immunol; 2022; 13():894919. PubMed ID: 36420264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer.
    French JD; Kotnis GR; Said S; Raeburn CD; McIntyre RC; Klopper JP; Haugen BR
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E934-43. PubMed ID: 22466343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.
    Yu H; Huang X; Liu X; Jin H; Zhang G; Zhang Q; Yu J
    Endocrine; 2013 Aug; 44(1):172-81. PubMed ID: 23264145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto's thyroiditis.
    Liu Y; Yun X; Gao M; Yu Y; Li X
    Clin Transl Oncol; 2015 Apr; 17(4):274-80. PubMed ID: 25387566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cytotoxic T cells and PD-1 immune checkpoint pathway in papillary thyroid carcinoma.
    Banerjee S; Nahar U; Dahiya D; Mukherjee S; Dey P; Gupta R; Radotra B; Sachdeva N; Sood A; Bhadada SK; Bhansali A
    Front Endocrinol (Lausanne); 2022; 13():931647. PubMed ID: 36518249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis.
    Zhu C; Dai Y; Zhang H; Ruan Y; Zhou Y; Dai Y; Fan L; Jia T; Lu H; Chen Q
    Diagn Pathol; 2021 Aug; 16(1):84. PubMed ID: 34465342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypical analysis of lymphocytes with suppressive and regulatory properties (Tregs) and NK cells in the papillary carcinoma of thyroid.
    Gogali F; Paterakis G; Rassidakis GZ; Kaltsas G; Liakou CI; Gousis P; Neonakis E; Manoussakis MN; Liapi C
    J Clin Endocrinol Metab; 2012 May; 97(5):1474-82. PubMed ID: 22399513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Cytometry Discovers Two Discrete Subsets of CD39
    Marsh-Wakefield F; Kruzins A; McGuire HM; Yang S; Bryant C; Fazekas de St Groth B; Nassif N; Byrne SN; Gibson J; Brown C; Larsen S; McCulloch D; Boyle R; Clark G; Joshua D; Ho PJ; Vuckovic S
    Front Immunol; 2019; 10():1596. PubMed ID: 31428081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Expression of GARP in Papillary Thyroid Carcinoma.
    Zhang X; Guo M; Yang J; Zheng Y; Xiao Y; Liu W; Ren F
    Endocr Pathol; 2019 Mar; 30(1):1-7. PubMed ID: 30443770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.
    French JD; Weber ZJ; Fretwell DL; Said S; Klopper JP; Haugen BR
    J Clin Endocrinol Metab; 2010 May; 95(5):2325-33. PubMed ID: 20207826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients.
    Schuler PJ; Schilling B; Harasymczuk M; Hoffmann TK; Johnson J; Lang S; Whiteside TL
    Eur J Immunol; 2012 Jul; 42(7):1876-85. PubMed ID: 22585562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer.
    Laumont CM; Wouters MCA; Smazynski J; Gierc NS; Chavez EA; Chong LC; Thornton S; Milne K; Webb JR; Steidl C; Nelson BH
    Clin Cancer Res; 2021 Jul; 27(14):4089-4100. PubMed ID: 33963000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer.
    Severson JJ; Serracino HS; Mateescu V; Raeburn CD; McIntyre RC; Sams SB; Haugen BR; French JD
    Cancer Immunol Res; 2015 Jun; 3(6):620-30. PubMed ID: 25701326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Effector Phenotype of Tim-3
    Liu Z; McMichael EL; Shayan G; Li J; Chen K; Srivastava R; Kane LP; Lu B; Ferris RL
    Clin Cancer Res; 2018 Sep; 24(18):4529-4538. PubMed ID: 29712685
    [No Abstract]   [Full Text] [Related]  

  • 17. Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and
    Hui Z; Zhang J; Zheng Y; Yang L; Yu W; An Y; Wei F; Ren X
    Front Immunol; 2021; 12():619932. PubMed ID: 33868236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCR usage, gene expression and function of two distinct FOXP3(+)Treg subsets within CD4(+)CD25(hi) T cells identified by expression of CD39 and CD45RO.
    Ye L; Goodall JC; Zhang L; Putintseva EV; Lam B; Jiang L; Liu W; Yin J; Lin L; Li T; Wu X; Yeo G; Shugay M; Chudakov DM; Gaston H; Xu H
    Immunol Cell Biol; 2016 Mar; 94(3):293-305. PubMed ID: 26467610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foxp3
    Liu L; Zhang Q; Chen P; Guo N; Song A; Huang X; Xia W; Li L; Moog C; Wu H; Su B; Zhang T
    BMC Immunol; 2019 Oct; 20(1):38. PubMed ID: 31651258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of expression of LGALS3BP gene in thyroid tissues and peripheral blood lymphocytes in patients with papillary thyroid cancer].
    Kaliszewski K; Łukieńczuk T; Dobosz T; Rzeszutko M; Sadakierska-Chudy A
    Endokrynol Pol; 2006; 57 Suppl A():38-44. PubMed ID: 17091455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.